Many people turn to energy drinks on tough days when regular coffee falls short. Late nights from work, studying, or family ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incor ...

The secret to a healthier and “younger” heart lies in the vagus nerve. A recent study coordinated by the Sant'Anna School of Advanced Studies in Pisa and published in Science Translational ...

Cytokinetics is committed to supporting patients with MYQORZO & You™, a personalized program for patients prescribed MYQORZO ...

Experts discourage regular consumption of energy drinks. High caffeine content paired with the supplemental ingredients in ...

German chamomile extract shows promise in lowering high blood pressure by relaxing blood vessels. Lab & animal studies reveal it modulates calcium channels & key proteins, likely due to compounds like ...

If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, ...

In August 2025, Sanofi acquired the rights to develop and commercialize Redemplo in Greater China from Visirna Therapeutics, a majority-owned subsidiary of Arrowhead Pharmaceuticals.

Iron is essential for oxygen transport and energy metabolism, yet both deficiency and excess are linked to cardiovascular risk. The National Library of Medicine shows that higher heme iron intake ...

MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...

After securing Medicare reimbursement for its pacemaker-like heart failure (HF) implant, Impulse Dynamics has raised more than $158 million to boost its production and commercial push. According to ...